1. Home
  2. CPIX vs AQMS Comparison

CPIX vs AQMS Comparison

Compare CPIX & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • AQMS
  • Stock Information
  • Founded
  • CPIX 1999
  • AQMS 2014
  • Country
  • CPIX United States
  • AQMS United States
  • Employees
  • CPIX N/A
  • AQMS N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • AQMS Metal Fabrications
  • Sector
  • CPIX Health Care
  • AQMS Industrials
  • Exchange
  • CPIX Nasdaq
  • AQMS Nasdaq
  • Market Cap
  • CPIX 17.2M
  • AQMS 18.0M
  • IPO Year
  • CPIX 2009
  • AQMS 2015
  • Fundamental
  • Price
  • CPIX $1.17
  • AQMS $1.81
  • Analyst Decision
  • CPIX
  • AQMS Strong Buy
  • Analyst Count
  • CPIX 0
  • AQMS 2
  • Target Price
  • CPIX N/A
  • AQMS $30.00
  • AVG Volume (30 Days)
  • CPIX 80.9K
  • AQMS 86.2K
  • Earning Date
  • CPIX 11-07-2024
  • AQMS 11-14-2024
  • Dividend Yield
  • CPIX N/A
  • AQMS N/A
  • EPS Growth
  • CPIX N/A
  • AQMS N/A
  • EPS
  • CPIX N/A
  • AQMS N/A
  • Revenue
  • CPIX $36,785,442.00
  • AQMS $25,000.00
  • Revenue This Year
  • CPIX N/A
  • AQMS N/A
  • Revenue Next Year
  • CPIX N/A
  • AQMS N/A
  • P/E Ratio
  • CPIX N/A
  • AQMS N/A
  • Revenue Growth
  • CPIX N/A
  • AQMS 525.00
  • 52 Week Low
  • CPIX $1.07
  • AQMS $1.85
  • 52 Week High
  • CPIX $2.36
  • AQMS $18.82
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 43.86
  • AQMS 26.77
  • Support Level
  • CPIX $1.15
  • AQMS $1.85
  • Resistance Level
  • CPIX $1.21
  • AQMS $2.15
  • Average True Range (ATR)
  • CPIX 0.08
  • AQMS 0.30
  • MACD
  • CPIX 0.00
  • AQMS -0.05
  • Stochastic Oscillator
  • CPIX 42.31
  • AQMS 8.20

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

Share on Social Networks: